Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Overbaugh

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Journal of Virology|December 28, 2012
Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup ARamon Mendoza, A Dusty Miller, Julie Overbaugh
Journal of Neurovirology|June 18, 2005
Risk factors for human immunodeficiency virus type-1 acquisition in women in AfricaSarah Benki, R Scott McClelland, Julie Overbaugh
Journal of Medical Primatology|June 24, 2015
Development of SHIVs with circulating, transmitted HIV-1 variantsAmit Sharma, David F Boyd, Julie Overbaugh
Advances in Virus Research|March 20, 2018
The Role of Immune Responses in HIV Mother-to-Child TransmissionCaitlin Milligan, Jennifer A Slyker, Julie Overbaugh
Journal of Virology|March 16, 2006
A putative thiamine transport protein is a receptor for feline leukemia virus subgroup ARamon Mendoza, Maria M Anderson, Julie Overbaugh
Biorxiv : the Preprint Server for Biology|February 17, 2023
Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4 <sup>+</sup> T cellsHannah L Itell, Daryl Humes, Julie Overbaugh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2007
The influence of hormonal contraceptive use on HIV-1 transmission and disease progressionJared M Baeten, Ludo Lavreys, Julie Overbaugh
Cell Reports|May 25, 2023
Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4<sup>+</sup> T cellsHannah L Itell, Daryl Humes, Julie Overbaugh
IAVI Report : Newsletter on International AIDS Vaccine Research|April 1, 2011
As antibody findings mount, what comes next? Interview by Kristen Jill Kresge and Regina McEneryDennis Burton, John Mascola, Nelson Michael, et al.
Journal of Virology|September 16, 2006
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivityManish Sagar, Xueling Wu, Sandra Lee, et al.
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Journal of Virology|December 28, 2012
Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup ARamon Mendoza, A Dusty Miller, Julie Overbaugh
Journal of Neurovirology|June 18, 2005
Risk factors for human immunodeficiency virus type-1 acquisition in women in AfricaSarah Benki, R Scott McClelland, Julie Overbaugh
Journal of Medical Primatology|June 24, 2015
Development of SHIVs with circulating, transmitted HIV-1 variantsAmit Sharma, David F Boyd, Julie Overbaugh
Advances in Virus Research|March 20, 2018
The Role of Immune Responses in HIV Mother-to-Child TransmissionCaitlin Milligan, Jennifer A Slyker, Julie Overbaugh
Journal of Virology|March 16, 2006
A putative thiamine transport protein is a receptor for feline leukemia virus subgroup ARamon Mendoza, Maria M Anderson, Julie Overbaugh
Biorxiv : the Preprint Server for Biology|February 17, 2023
Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4 <sup>+</sup> T cellsHannah L Itell, Daryl Humes, Julie Overbaugh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2007
The influence of hormonal contraceptive use on HIV-1 transmission and disease progressionJared M Baeten, Ludo Lavreys, Julie Overbaugh
Cell Reports|May 25, 2023
Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4<sup>+</sup> T cellsHannah L Itell, Daryl Humes, Julie Overbaugh
IAVI Report : Newsletter on International AIDS Vaccine Research|April 1, 2011
As antibody findings mount, what comes next? Interview by Kristen Jill Kresge and Regina McEneryDennis Burton, John Mascola, Nelson Michael, et al.
Journal of Virology|September 16, 2006
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivityManish Sagar, Xueling Wu, Sandra Lee, et al.
Pageof 27